Business Context and Reporting Period
This Form 8-K is a current report filed by Amedica Corporation (not Sintx Technologies, Inc.) on July 22, 2015, regarding events occurring on July 17, 2015. The filing discloses the entry into material definitive agreements concerning executive compensation and change of control provisions.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and executive compensation agreements rather than financial performance data.
Material Changes and Agreements
On July 17, 2015, the Company entered into Change of Control Agreements with key executives, including CEO B. Sonny Bal, MD, and VP of Finance Ty Lombardi. Key provisions include:
- Acceleration of Equity: Upon a change in control, all outstanding options, restricted stock, and similar rights held by the executives will fully vest.
- Severance Payments: If an executive is terminated without cause or resigns for "good reason" within one year of a change in control, they are entitled to a lump sum payment equal to one-half of their highest annual salary (including bonuses) from the preceding three-year period.
- Excise Tax Gross-Up: The Company is obligated to provide a "gross up" payment to cover any excise taxes under Section 4999 of the Internal Revenue Code resulting from these payments.
Definitions and Triggers
The agreements define a "Change in Control" as occurring upon:
- Any person becoming the beneficial owner of 50% or more of the voting power (excluding approved transactions).
- A merger or consolidation where pre-transaction voting securities do not represent at least 50% of the surviving entity.
- Stockholder approval of the sale or disposition of all or substantially all assets.
"Cause" includes felony commission, disloyalty, fraud, material breach of agreement, or refusal to follow lawful directives. "Good reason" includes a relocation of 50+ miles or a material reduction in compensation or authority.
Investor Verification Checklist
- Verify the exact terms of the Change of Control Agreements in Exhibit 10.1.
- Confirm the current outstanding equity awards held by B. Sonny Bal, MD, and Ty Lombardi to assess potential dilution upon a change in control.
- Review the Company's cash reserves to determine the ability to fund potential severance payments and tax gross-ups.
- Monitor for any pending merger, acquisition, or significant asset sale discussions that could trigger these agreements.